|
As the world watched, the first approved COVID-19 vaccines were transported to the UK to start the mass immunisation process.
The global attention not only highlighted how the pharmaceutical manufacturing and supply chain sectors were working together to rapidly respond in the fight against the virus, it also focused on the cold chain challenges associated with the deployment and safe transportation of COVID-19 vaccines.
These challenges will continue to evolve as various vaccines, with varying temperature requirements for storage and shipment, are approved and transported worldwide.
Cold chain protection, throughout this distribution process, is essential. This can be packaging, or buildings and vehicles, but most crucial is a process to establish an unbroken cold chain. Colder temperatures are more difficult to maintain, as they may require more exotic coolants, such as dry ice, to achieve -80°C.
|
